Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of an artificial intelligence-based medical device for diagnosis of autism spectrum disorder.
Megerian JT, Dey S, Melmed RD, Coury DL, Lerner M, Nicholls CJ, Sohl K, Rouhbakhsh R, Narasimhan A, Romain J, Golla S, Shareef S, Ostrovsky A, Shannon J, Kraft C, Liu-Mayo S, Abbas H, Gal-Szabo DE, Wall DP, Taraman S. Megerian JT, et al. Among authors: melmed rd. NPJ Digit Med. 2022 May 5;5(1):57. doi: 10.1038/s41746-022-00598-6. NPJ Digit Med. 2022. PMID: 35513550 Free PMC article.
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome.
Bird LM, Ochoa-Lubinoff C, Tan WH, Heimer G, Melmed RD, Rakhit A, Visootsak J, During MJ, Holcroft C, Burdine RD, Kolevzon A, Thibert RL. Bird LM, et al. Among authors: melmed rd. Neurology. 2021 Feb 16;96(7):e1024-e1035. doi: 10.1212/WNL.0000000000011409. Epub 2020 Dec 21. Neurology. 2021. PMID: 33443117 Free PMC article. Clinical Trial.
The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.
Herscu P, Handen BL, Arnold LE, Snape MF, Bregman JD, Ginsberg L, Hendren R, Kolevzon A, Melmed R, Mintz M, Minshew N, Sikich L, Attalla A, King B, Owley T, Childress A, Chugani H, Frazier J, Cartwright C, Murphy T; Autism Speaks Autism Clinical Trials Network. Herscu P, et al. Among authors: melmed r. J Autism Dev Disord. 2020 Sep;50(9):3233-3244. doi: 10.1007/s10803-019-04120-y. J Autism Dev Disord. 2020. PMID: 31267292 Clinical Trial.
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
Schroder CM, Malow BA, Maras A, Melmed RD, Findling RL, Breddy J, Nir T, Shahmoon S, Zisapel N, Gringras P. Schroder CM, et al. Among authors: melmed rd. J Autism Dev Disord. 2019 Aug;49(8):3218-3230. doi: 10.1007/s10803-019-04046-5. J Autism Dev Disord. 2019. PMID: 31079275 Free PMC article. Clinical Trial.
Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies.
Hardan AY, Hendren RL, Aman MG, Robb A, Melmed RD, Andersen KA, Luchini R, Rahman R, Ali S, Jia XD, Mallick M, Lateiner JE, Palmer RH, Graham SM. Hardan AY, et al. Among authors: melmed rd. Autism. 2019 Nov;23(8):2096-2111. doi: 10.1177/1362361318824103. Epub 2019 Apr 26. Autism. 2019. PMID: 31027422 Free PMC article. Clinical Trial.
Investigation of Escherichia coli Harboring the mcr-1 Resistance Gene - Connecticut, 2016.
Vasquez AM, Montero N, Laughlin M, Dancy E, Melmed R, Sosa L, Watkins LF, Folster JP, Strockbine N, Moulton-Meissner H, Ansari U, Cartter ML, Walters MS. Vasquez AM, et al. Among authors: melmed r. MMWR Morb Mortal Wkly Rep. 2016 Sep 16;65(36):979-80. doi: 10.15585/mmwr.mm6536e3. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27631346 Free article.
Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
Aman MG, Findling RL, Hardan AY, Hendren RL, Melmed RD, Kehinde-Nelson O, Hsu HA, Trugman JM, Palmer RH, Graham SM, Gage AT, Perhach JL, Katz E. Aman MG, et al. Among authors: melmed rd. J Child Adolesc Psychopharmacol. 2017 Jun;27(5):403-412. doi: 10.1089/cap.2015.0146. Epub 2016 Mar 15. J Child Adolesc Psychopharmacol. 2017. PMID: 26978327 Free PMC article. Clinical Trial.
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH. Erickson CA, et al. Among authors: melmed rd. J Autism Dev Disord. 2014 Apr;44(4):958-64. doi: 10.1007/s10803-013-1963-z. J Autism Dev Disord. 2014. PMID: 24272415 Clinical Trial.
Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder.
Napolioni V, Ober-Reynolds B, Szelinger S, Corneveaux JJ, Pawlowski T, Ober-Reynolds S, Kirwan J, Persico AM, Melmed RD, Craig DW, Smith CJ, Huentelman MJ. Napolioni V, et al. Among authors: melmed rd. J Neuroinflammation. 2013 Mar 14;10:38. doi: 10.1186/1742-2094-10-38. J Neuroinflammation. 2013. PMID: 23497090 Free PMC article.
96 results